Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$13K Hold
6,000
0.02% 329
2022
Q2
$21K Hold
6,000
0.03% 269
2022
Q1
$30K Buy
6,000
+1,000
+20% +$5.07K 0.04% 228
2021
Q4
$31K Sell
5,000
-400
-7% -$2.73K 0.04% 220
2021
Q3
$38K Buy
+5,400
New +$44.5K 0.05% 180

Other funds holding VXRT

Strategic Asset Management's VXRT Position: Q3 2022 in Review

Strategic Asset Management held its Vaxart (VXRT) position steady in Q3 2022 at 6,000 shares worth $13K. The position accounts for 0.02% of the portfolio, ranked #329.

Strategic Asset Management first reported a position in VXRT in Q3 2021 and has held it in 5 quarters since. The position peaked at $38K in Q3 2021. 143 funds tracked by Wall St. Rank hold VXRT as of Q3 2022.

  • Strategic Asset Management held 6,000 shares of Vaxart worth $13K as of Q3 2022.
  • Strategic Asset Management left its Vaxart share count unchanged in Q3 2022.
  • Vaxart made up 0.02% of Strategic Asset Management's portfolio in Q3 2022, its #329 holding.
  • Strategic Asset Management first reported a position in Vaxart in Q3 2021 and has held it in 5 quarters since.
  • Strategic Asset Management's Vaxart position peaked at $38K in Q3 2021.
  • 143 funds tracked by Wall St. Rank held Vaxart as of Q3 2022.

Based on Strategic Asset Management's 13F filing for Q3 2022, filed 1 Nov 2022.